Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    17765963 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Blood Pressure and Glucose Lowering for the Prevention of Vascular Disease in High Risk Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Perindopril-indapamide;   Drug: Gliclazide MR-based glucose lowering
2 Completed Action in Diabetes and Vascular Disease Preterax and Diamicron MR Controlled Evaluation Post Trial Observational Study
Condition: Diabetes Mellitus, Type 2
Intervention:

Indicates status has not been verified in more than two years